TT

Tejal Tejasbhai Hathi

Director Director DIN 10448329
DIN 10448329 First appointment Jan 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2024
Shareholding value Locked Premium profile

About Tejal Tejasbhai Hathi

Data last updated:

Tejal Tejasbhai Hathi has 2 years in corporate governance. Formerly with 1 company, such as Aptus Pharma Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10448329
Primary Designation Director
First Appointment 17 Jan 2024
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Aptus Pharma Limited U24230GJ2010PLC061957
Director17 Jan 20242010Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aptus Pharma Limited
Premium access

Shareholding and investment profile for Tejal Tejasbhai Hathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tejal Tejasbhai Hathi

Tejal Tejasbhai Hathi has 2 years in corporate governance. Formerly with 1 company, such as Aptus Pharma Limited. Engaged in General Business. Contributes to corporate operations.

Tejal Tejasbhai Hathi is associated with 0 companies as a director.

Tejal Tejasbhai Hathi has expertise in General Business.

Tejal Tejasbhai Hathi has 2 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available